Overview
This page compares USDS and Injective with live PEPS metrics. Rankings (#12 vs #99) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | USDS | INJ |
|---|---|---|
| Price | $1.00 | $5.12 |
| Market Cap | $9.72B | $512.13M |
| FDV | — | — |
| Volume 24h | $224,458.65 | $34.09M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 12.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USDS | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.01% | +4.40% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USDS | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across USDS and Injective, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | USDS | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USDS
Injective
Pros and cons
Pros of USDS
- Market-cap scale on USDS may dampen some idiosyncratic shocks versus smaller peers.
- USDS typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- USDS has an established coin page footprint on PEPS for continuous monitoring.
- USDS often anchors narratives that attract sustained media and analyst coverage.
Cons of USDS
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Regulatory or macro headlines can hit USDS harder simply because it is more visible.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Injective can offer higher relative beta when market attention rotates toward its niche.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Smaller book depth versus large caps can increase slippage for Injective.
- Relative underperformance versus USDS can persist through entire market regimes.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. USDS and Injective can alternate leadership as macro liquidity and narrative rotate.
AI summary
Comparing USDS and INJ begins with structure: capitalization, volume and rank. Present prints are $1.00 versus $5.12. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-USDS pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, USDS or Injective?
“Better” depends on horizon and risk. USDS leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USDS or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USDS and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.